Get started
Author

Ulrich‐Peter Rohr

The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report
2016 · Ulrich-Peter Rohr, Carmen Binder, et al. · PLoS ONE · 243
PDF
Bevacizumab Safety in Patients with Central Nervous System Metastases
2009 · Benjamin Besse, Susan F. Lasserre, et al. · Clinical Cancer Research · 240
PDF
Venous Thromboembolic Events With Chemotherapy Plus Bevacizumab: A Pooled Analysis of Patients in Randomized Phase II and III Studies
2011 · Herbert I. Hurwitz, Leonard B. Saltz, et al. · Journal of Clinical Oncology · 227
Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies
2009 · James Cassidy, Leonard B. Saltz, et al. · Journal of Cancer Research and Clinical Oncology · 159
PDF
Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells
2002 · Ulrich Steidl, Ralf Kronenwett, et al. · Blood · 148
PDF
Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR
2002 · Ulrich-Peter Rohr, Marc-Andre Wulf, et al. · Journal of Virological Methods · 146
Tumor immune escape by the loss of homeostatic chemokine expression
2007 · Andor Pivarcsi, Anja Müller, et al. · Proceedings of the National Academy of Sciences · 141
Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody
2001 · G Kobbe, P Schneider, et al. · Bone Marrow Transplantation · 134
Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators
2004 · Ulrich Steidl, Simone Bork, et al. · Blood · 133
FDA Approval Summary: Osimertinib for Adjuvant Treatment of Surgically Resected Non–Small Cell Lung Cancer, a Collaborative Project Orbis Review
2021 · Abigail L. Koch, Paz J. Vellanki, et al. · Clinical Cancer Research · 68
A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma
2005 · Ingmar Bruns, Ulrich Steidl, et al. · Transfusion · 67
Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers
2008 · Astrid Rohrbeck, Judith Neukirchen, et al. · Journal of Translational Medicine · 64
PDF
Expression of the tyrosine kinase c‐kit is an independent prognostic factor in patients with small cell lung cancer
2004 · Ulrich‐Peter Rohr, Nina Rehfeld, et al. · International Journal of Cancer · 51
PDF
The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer.
2006 · Nina Rehfeld, Helene Geddert, et al. · Journal of Carcinogenesis · 38
PDF
Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma.
2004 · Roland Fenk, Muharrem Ak, et al. · PubMed · 35
Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles
2005 · Ulrich-Peter Rohr, Florian Heyd, et al. · Journal of Virological Methods · 34
Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies
2017 · U.-P. Rohr, P. Herrmann, et al. · Annals of Oncology · 30
Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair–Proficient Stage II Colon Cancer
2016 · Pradipta Ghosh, Jeanne Tie, et al. · Clinical Cancer Research · 30
Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma
2006 · Claudia Papewalis, Martin Fassnacht, et al. · Clinical Endocrinology · 22
Inhibition of angiogenesis in vitro by αv integrin–directed antisense oligonucleotides
2002 · Ralf Kronenwett, Thorsten Gräf, et al. · Cancer Gene Therapy · 22
Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests
2015 · Mogens Vyberg, Søren Nielsen, et al. · BMC Health Services Research · 21
PDF
Effect of Project Orbis participation by the Swiss regulator on submission gaps, review times, and drug approval decisions between 2020 and 2022: a comparative analysis
2024 · Matea Zosso-Pavic, Qiyu Li, et al. · The Lancet Oncology · 19
Regulatory Review Duration and Differences in Submission Times of Drugs in the United States and Europe, 2011 to 2020
2023 · Kerstin N. Vokinger, Miquel Serra-Burriel, et al. · Annals of Internal Medicine · 18
Primary human cells differ in their susceptibility to rAAV-2-mediated gene transfer and duration of reporter gene expression
2002 · Ulrich-Peter Rohr, Ralf Kronenwett, et al. · Journal of Virological Methods · 16
Prognostic Relevance of Fragile Histidine Triad Protein Expression in Patients with Small Cell Lung Cancer
2005 · Ulrich-Peter Rohr, Nina Rehfeld, et al. · Clinical Cancer Research · 15
Works count: 57
Citation count: 2,194
H-index: 21
I10-index: 28
Year
Topic
Type